19 C
New York
Friday, June 9, 2023

This Is Too Hot For Novo Nordisk A/S (NYSE: NVO), Let’s Take A Closer Look

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Novo Nordisk A/S (NVO) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.45, or 0.27%, to $169.00. The Novo Nordisk A/S has recorded 3,065 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons.

<25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.


Stocks Info

As a NYSE listed company, NVO falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $168.55 and fluctuated between $168.69 as its day high and $167.15 as its day low. The current market capitalization of Novo Nordisk A/S is $288.11B. A total of 0.7 million shares were traded on the day, compared to an average of 1.35M shares.


Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Novo Nordisk A/S pays an annual dividend of $1.76, resulting in a dividend yield of 1.04%, and it has a price to earnings (P/E) ratio of 42.78. NVO’s most recent ex-dividend date was 3/24/2023 when it declared a $1.1887 quarterly dividend that was paid in cash on 4/4/2023. Previously, the company paid the dividend on 8/23/2022 with an ex-dividend date of 8/12/2022. The NVO stock dividend was $0.5836 per share in cash.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for NVO in the last 3 months, the mean price target is $171.36 with high estimates of $211.53 and low estimates of $99.68. In terms of 52-week highs and lows, NVO has a high of $172.97 and a low of $95.02.

As of this writing, NVO has an earnings estimate of $1.24 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of $1.29 per share and a lower estimate of $1.2. The company reported an EPS of $0.87 in the last quarter, which was 2.40% higher than expectations of $0.85.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. NVO’s latest balance sheet shows that the firm has $17.48B in Cash & Short Term Investments as of fiscal 2021. There were $26.64B in debt and $99.52B in liabilities at the time. Its Book Value Per Share was $5.20, while its Total Shareholder’s Equity was $70.75B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVO is Buy with a score of 4.10.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles